Hutzler, Stefan <br/><br/>
Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles.  [electronic resource] 

 -  Scientific reports  12 2017 
 - 16892 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-017-16928-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigen Presentation<br/>Antigens, Neoplasm--genetics<br/>Autoantibodies--blood<br/>Cancer Vaccines--genetics<br/>Cell Line, Tumor<br/>Chlorocebus aethiops<br/>Claudins--genetics<br/>Immunity, Cellular<br/>Immunity, Humoral<br/>Interferon-gamma--metabolism<br/>Lung Neoplasms--secondary<br/>Measles virus--genetics<br/>Melanoma, Experimental--immunology<br/>Mice<br/>Mice, Transgenic<br/>Oncolytic Virotherapy<br/>Ovalbumin--genetics<br/>Vaccines, Virus-Like Particle--genetics<br/>Vero Cells